NEXGEL director buys $1M note and stock warrant
NEXGEL director Brian Joseph Kieser bought a $1,000,000 Convertible Promissory Note and received a large stock warrant as part of the same financing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEXGEL director Brian Joseph Kieser bought a $1,000,000 Convertible Promissory Note and received a large stock warrant as part of the same financing. The Note can be converted into up to 1,666,667 shares of common stock at $0.60 per share. The warrant is exercisable for 833,334 shares at $0.80 per share. Both instruments are convertible or exercisable at the holder’s option but are subject to a 4.99% beneficial-ownership limitation on NEXGEL’s outstanding common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Convertible Promissory Note (the "Note") | 1,666,667 | $0.60 | $1.00M |
| Purchase | Warrant to Purchase Common Stock (the "Warrant") | 833,334 | $0.00 | $0.00 |
Footnotes (2)
- F1. Reflects the issuance to the Reporting Person of (i) a Convertible Promissory Note in the original principal amount of $1,000,000 (the "Note") and (ii) a Warrant to Purchase Common Stock for 833,334 shares of the Issuer's common stock (the "Common Stock") (the "Warrant"). The Note is convertible into up to 1,666,667 shares of Common Stock at an initial conversion price of $0.60 per share, and the Warrant is exercisable for 833,334 shares of Common Stock at an initial exercise price of $0.80 per share. The Note is convertible, and the Warrant is exercisable, at any time at the option of the holder, subject to (i) a beneficial-ownership limitation that prevents conversion or exercise to the extent the holder, together with its affiliates, would beneficially own more than 4.99% of the outstanding shares of Common Stock after such conversion or exercise, and (ii) certain other limitations set forth in the Note and Warrant.
- F2. The Warrant was issued to the Reporting Person in connection with, and as part of the consideration for, the Reporting Person's purchase of the Note, for no additional consideration beyond the Note purchase price.
Key Figures
Key Terms
Convertible Promissory Note financial
Warrant to Purchase Common Stock financial
initial conversion price financial
initial exercise price financial
beneficial-ownership limitation regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NEXGEL (NXGL) director Brian Joseph Kieser buy in this Form 4?
What are the conversion and exercise prices in this NEXGEL (NXGL) insider deal?
Is there an ownership cap on Brian Joseph Kieser’s NEXGEL (NXGL) Note and Warrant?
Was the NEXGEL (NXGL) Warrant purchased separately from the Note?
AI-generated analysis. How Rhea-AI works. Not financial advice.